These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 2319512

  • 1. Development of beta-lactamase inhibitors.
    Sutherland R.
    J Reprod Med; 1990 Mar; 35(3 Suppl):307-12. PubMed ID: 2319512
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evolution of beta-lactamase inhibitors.
    Jackson D.
    Pharmacotherapy; 1991 Feb; 11(2 ( Pt 2)):37S-39S. PubMed ID: 2041830
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity.
    Hardin TC, Butler SC, Ross S, Wakeford JH, Jorgensen JH.
    Pharmacotherapy; 1994 Feb; 14(2):147-52. PubMed ID: 8197032
    [Abstract] [Full Text] [Related]

  • 12. Beta-lactamase inhibitors from laboratory to clinic.
    Bush K.
    Clin Microbiol Rev; 1988 Jan; 1(1):109-23. PubMed ID: 3060240
    [Abstract] [Full Text] [Related]

  • 13. Interaction of clavulanic acid, sulbactam and cephamycin antibiotics with beta-lactamases.
    Grace ME, Fu KP, Gregory FJ, Hung PP.
    Drugs Exp Clin Res; 1987 Jan; 13(3):145-8. PubMed ID: 3040368
    [Abstract] [Full Text] [Related]

  • 14. Ampicillin-sulbactam and ticarcillin-clavulanic acid: a comparison of their in vitro activity and review of their clinical efficacy.
    Itokazu GS, Danziger LH.
    Pharmacotherapy; 1991 Jan; 11(5):382-414. PubMed ID: 1745624
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of beta-lactamase-mediated antimicrobial resistance: the role of beta-lactamase inhibitors.
    Maddux MS.
    Pharmacotherapy; 1991 Jan; 11(2 ( Pt 2)):40S-50S. PubMed ID: 2041831
    [Abstract] [Full Text] [Related]

  • 18. Potentiation of human polymorphonuclear leukocyte phagocytosis and intracellular bactericidal activity by amoxycillin/clavulanic acid.
    Cuffini AM, De Renzi G, Tullio V, Paizis G, Carlone NA.
    Drugs Exp Clin Res; 1996 Jan; 22(1):9-15. PubMed ID: 8839632
    [Abstract] [Full Text] [Related]

  • 19. Evolution of beta-lactamase inhibitors.
    Rolinson GN.
    J Reprod Med; 1988 Jun; 33(6 Suppl):571-3. PubMed ID: 3294401
    [Abstract] [Full Text] [Related]

  • 20. Novel imidazole substituted 6-methylidene-penems as broad-spectrum beta-lactamase inhibitors.
    Venkatesan AM, Agarwal A, Abe T, Ushirogochi H, Yamamura I, Kumagai T, Petersen PJ, Weiss WJ, Lenoy E, Yang Y, Shlaes DM, Ryan JL, Mansour TS.
    Bioorg Med Chem; 2004 Nov 15; 12(22):5807-17. PubMed ID: 15498657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.